ctrl K

Price Alert

Adverum Biotechnologies I... (ADVM)

NASDAQ: ADVM · Real-Time Price · USD

2.82

0.05 (1.81%)

At close: Aug 15, 2025, 3:59 PM

2.81

-0.35%

After-hours: Aug 15, 2025, 06:04 PM EDT

Adverum Biotechnologies Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	60.65M	75M	68.43M	34.2M
Short-Term Investments	65.04M	21.53M	117.16M	270.99M
Long-Term Investments	1.98M	1.98M	2.5M	3.27M
Other Long-Term Assets	1.35M	1.23M	1.41M	250K
Receivables	n/a	n/a	n/a	5.71M
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	5.61M	6.25M	5.01M	n/a
Total Current Assets	131.3M	102.77M	190.59M	317.14M
Property-Plant & Equipment	45.22M	67.03M	113.86M	119.06M
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	48.54M	70.24M	117.78M	122.58M
Total Assets	179.84M	173.01M	308.37M	439.73M
Account Payables	1.61M	1.92M	2.24M	1.39M
Deferred Revenue	n/a	n/a	n/a	16.03M
Short-Term Debt	n/a	n/a	n/a	1.89M
Other Current Liabilities	5.96M	-490K	9.13M	-6.69M
Total Current Liabilities	22.9M	19.98M	32.25M	21.32M
Long-Term Debt	86.04M	64.63M	93.56M	101.11M
Other Long-Term Liabilities	192K	n/a	1.05M	1.11M
Total Long-Term Liabilities	86.23M	68.56M	94.61M	102.22M
Total Liabilities	109.13M	89.54M	126.85M	123.54M
Total Debt	91.7M	74.04M	106.8M	102.99M
Common Stock	2K	10K	10K	10K
Retained Earnings	-1.07B	-919.78M	-802.61M	-648.08M
Comprehensive Income	-407K	-473K	-1.53M	-714K
Shareholders Equity	70.71M	83.47M	181.52M	316.19M
Total Investments	65.04M	23.5M	119.66M	274.26M